0001104659-21-154012.txt : 20211228
0001104659-21-154012.hdr.sgml : 20211228
20211228190416
ACCESSION NUMBER: 0001104659-21-154012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211227
FILED AS OF DATE: 20211228
DATE AS OF CHANGE: 20211228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Naftzger J. Christopher
CENTRAL INDEX KEY: 0001496194
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 211525937
MAIL ADDRESS:
STREET 1: 633 LOWTHER ROAD
CITY: LEWISBERRY
STATE: PA
ZIP: 17339
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25-28 NORTH WALL QUAY
CITY: DUBLIN
STATE: L2
ZIP: D01 H104
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 414 COMMERCE DRIVE
STREET 2: STE 120
CITY: FORT WASHINGTON
STATE: PA
ZIP: 19034
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
tm2136401-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-27
0
0001641640
Nabriva Therapeutics plc
NBRV
0001496194
Naftzger J. Christopher
414 COMMERCE DR.
SUITE 120
FORT WASHINGTON
PA
19034
0
1
0
0
General Counsel and Corp Sec
Ordinary Shares
2021-12-27
4
P
0
7000
0.59
A
7000
D
/s/ Daniel Dolan, by power of attorney
2021-12-28